Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Medtronic
The REVERSE PAS will estimate the 3-year survival probability of freedom from heart failure hospitalization and heart failure events in patients implanted with a Medtronic CRT-D device who meet the expanded indication criteria with a QRS duration ≤ 150 ms.
Age
Any age
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patient or legally authorized representative provides written authorization and/or consent per institution and geographical requirements
Patient has or is intended to receive or be treated with a Medtronic CRT-D who meets the expanded CRT-D indication criteria with a QRS ≤ 150ms
Patient within 30 days of implant
You may not be if
Patient who is, or will be, inaccessible for follow-up
Patient is currently enrolled in or plans to enroll in any concurrent drug and/or device study that may confound results
Clareo Health | The Product Surveillance Registry REVERSE Post Approval Study
